HBIO: Rega Tumbas Perusahaan Harvard Bioscience, Inc.

The market trend for Harvard Bioscience (HBIO) shown on this price chart reflects an enterprise value of 75.59. The business's moat relies on the ownership of unique patents and strict FDA oversight, which limits the entry of new players. Harvard Bioscience provides core equipment for global laboratories, facilitating cell research. The current strategic vector is focused on releasing high-margin precision dosing and analysis systems.

HBIO (Harvard Bioscience, Inc.) riwayat Nilai Total Perusahaan saka 23.11.2025 nganti 27.10.2026

HBIO (Harvard Bioscience): rincian analitis lan laporan miturut indikator

- rega lan prakiraan konsensus rega:

Bagan rega Harvard Bioscience Inc.|HBIO - Prakiraan konsensus analis

- data kapitalisasi pasar:

Kapitalisasi pasar Harvard Bioscience|HBIO - Nilai Total Perusahaan

- data kapitalisasi buku:

Nilai Aset Bersih saben Saham Harvard Bioscience|HBIO - Nilai Buku Perusahaan|Rasio Kapitalisasi marang Aset Bersih harvardbioscience.com|HBIO - Total Aset Perusahaan

- data utang lan likuiditas:

Utang marang Modal Harvard Bioscience|HBIO - Utang jangka dawa marang modal|Rasio utang jangka cendhak marang modal harvardbioscience.com|HBIO - Gunggung utang perusahaan|Utang-utang marang aset resik Harvard Bioscience

Analisis umum perusahaan:HBIO (Harvard Bioscience Inc.)

Enterprise value determines the total cost of a full business buyout, accounting for all liabilities. This metric combines market capitalization and net debt, excluding available cash. Analyzing the full fundamental value of the company allows for an assessment of the asset's real price. The trend in the full fundamental value of Harvard Bioscience (HBIO) reflects the investment attractiveness of its robotic systems. High values for this metric confirm the market value of its automated biomonitoring equipment.

Analisis pesaing Harvard Bioscience